María Ángeles Vázquez-Sánchez

María Ángeles Vázquez-Sánchez

Auto-generated profile, based on publicly available information

María Ángeles Vázquez-Sánchez

Safety and Sustainability Division, Leitat Technological Center , Barcelona 08028, Spain

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2016 in Journal of Proteome Research
Verified
Journal Article
Closed access
Julia KuligowskiJulia Kuligowski
Julia Kuligowski
DSDaniel Sanjuan-Herráez
Daniel Sanjuan-Herráez
MVMaría A. Vázquez-Sánchez
María A. Vázquez-Sánchez
ABAnna Brunet-Vega
Anna Brunet-Vega
CPCarles Pericay
Carles Pericay
Guillermo QuintásGuillermo Quintás
Guillermo Quintás

8 July 2011 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
Santiago Ramo´n y CajalSantiago Ramo´n y Cajal
Santiago Ramo´n y Cajal
BPBerta Pons
Berta Pons
VPVicente Peg
Vicente Peg
MVMaría Ángeles Vázquez-Sánchez
María Ángeles Vázquez-Sánchez
LLLaura López-Vicente
Laura López-Vicente
Gemma ArmengolGemma Armengol
Gemma Armengol
Cell signaling pathways and protein translation are crucial for understanding malignant transformation. 4E-BP1 and the eIF4F complex regulate cap-dependent translation. We investigated how 4E-BP1 and eIF4E phosphorylation status affects in vitro and in vivo cell proliferation in a breast cancer model. Cells from 2 breast carcinoma lines (MDA-MB 231 and MDA-MB 468) and human fibroblasts (IMR90 cells) were infected in vitro with a retrovirus carrying a wild-type 4E-BP1 or a mutant 4E-BP1 unable to hyperphosphorylate. Overexpression of the mutant 4E-BP1 induced a significant decrease in cell proliferation in IMR90 and MDA-MB 468 cells, but not in MDA-MB 231 cells. A correlation was observed between baseline-phosphorylated eIF4E (p-eIF4E) levels and sensitivity to 4E-BP1 transduction. By co-immunoprecipitation, p-eIF4E seemed to present lower affinity for 4E-BP1 than total eIF4E in MDA-MB 468 cells. After treatment with CGP57380, the MAP kinase-interacting kinase (MNK) inhibitor, downregulation of p-eIF4E levels was associated with an increase of E-cadherin and β-catenin protein expression. These results provide evidence that 4E-BP1 transduction leads to a decrease in cell proliferation, and that high p-eIF4E levels may counteract the suppressor effect of 4E-BP1. We propose that high p-4E-BP1 and p-eIF4E levels are central factors in cell signaling and reflect the oncogenic potential of cell signaling pathways in breast cancer.

6 August 2015 in Current Protocols in Toxicology
Verified
Journal Article
Open access
PDF file
FTFrancisco M. Torres
Francisco M. Torres
ZSZsolt Sáfár
Zsolt Sáfár
MVMaria A. Vázquez‐Sánchez
Maria A. Vázquez‐Sánchez
AKAnita Kurunczi
Anita Kurunczi
EKEmese Kis
Emese Kis
PKPéter Krajcsi
Péter Krajcsi
Membrane transporters significantly modulate membrane permeability of endobiotics and xenobiotics, such as bile acids and drugs, respectively. Various in vitro methods have been established for both ATP-binding cassette (ABC) transporters to examine cellular efflux and uptake, and for solute carriers (SLC) to examine cellular uptake of substrates. Cell-based systems are the models of choice to test drug-transporter interactions as well as drug-drug interactions for research and regulatory purposes, albeit, for low passive permeability substrates of ABC transporters, vesicular uptake assays are also recommended. Commercially available pre-plated cells (e.g., immortalized or transfected) offer a useful alternative to in-house cell culture. Three main methods are known to manufacture pre-plated cultures: regular culture medium with vacuum seal, cryopreserved delivery, and the solid shipping media technology. The regular culture medium and the solid shipping media technologies provide ready-to-use models for end users. Models expressing a broad selection of transporters are available in pre-plated formats for absorption, distribution, metabolism, excretion, and toxicity (ADMETox) studies. Conversely, the application and utility of pre-plated cultures coupled with personal experiences have not been extensively covered in published research papers or reviews, despite availability and significant use of pre-plated products in the pharmaceutical industry. In this overview, we will briefly describe: 1) in vitro tools commonly used for ADMETox testing; 2) methods employed in manufacturing, shipment and preparation of pre-plated cell lines; 3) cell-membrane barrier models currently available in pre-plated format to reproduce passage restriction of physiological barriers to certain compounds; and 4) recommended pre-plated cell lines overexpressing uptake transporters for ADMETox applications. © 2015 by John Wiley & Sons, Inc.